Global Antiperspirant

Antiperspirant Comprehensive Study by Type (Roll-On Antiperspirants, Spray Antiperspirants, Stick Antiperspirants), Application (Men, Women), End-users (Men, Women), Distribution Channel (Supermarket/Hypermarket, Convenience Stores, Specialty Stores, Online Stores) Players and Region - Global Market Outlook to 2028

Antiperspirant Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Antiperspirant Market?

Antiperspirant includes active ingredients usually aluminum-based compounds that temporarily block sweat pores. It is used as the first line of treatment for excessive sweating of the hands, underarms, feet, and sometimes face. It is applied to the top of the skin (which is why you sometimes hear them called "topical" treatments).

Highlights from Antiperspirant Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledUnilever plc (United Kingdom), Amway (United States), Beiersdorf AG (Germany), Mentholatum (United States), Coty Inc. (United States), Avon Products, Inc. (United Kingdom), Shanghai Jahwa United Co., Ltd. (China), Gialen Cosmetics (China) and Sephora (France)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Global Vendors will contribute to the maximum growth of Global Antiperspirant market throughout the forecasted period.

Unilever plc (United Kingdom), Amway (United States), Beiersdorf AG (Germany), Mentholatum (United States), Coty Inc. (United States), Avon Products, Inc. (United Kingdom), Shanghai Jahwa United Co., Ltd. (China), Gialen Cosmetics (China) and Sephora (France) are some of the key players profiled in the study.

Antiperspirant Market Segmentation:
ScopeSub-Segments
Application / End UserMen and Women
TypeRoll-On Antiperspirants, Spray Antiperspirants and Stick Antiperspirants
End-usersMen,Women
Distribution ChannelSupermarket/Hypermarket,Convenience Stores,Specialty Stores,Online Stores


On the basis of geography, the market of Antiperspirant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Robust Increase in the Distribution Channels and Increased Number of Online Customers

Market Growth Drivers:
Increased Prevalence of Excessive Sweating among People, High Benefits of the Antiperspirant and Increased Number of Promotional Activities by Manufacturers

Challenges:
Less Awareness about Antiperspirant in Some regions

Restraints:
Side Effects of Antiperspirant

Opportunities:
Growth in the Cosmetic Industry, Huge Investments by Major Players and Increasing Demand from End-users

Key Target Audience
Antiperspirant Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users

Market Leaders & Development Strategies
In August 2019, Beiersdorf acquired Coppertone. Coppertone’s global operations transferred from Bayer to Beiersdorf. This acquisition helped company to expand its presence in antiperspirant market
In November 2020, Unilever completed the unification of its Group legal structure under a single parent company, Unilever PLC and maintain the Group’s listings on the Amsterdam, London and New York stock exchanges. This unification strengthened the company’s position in antiperspirant market


Report Objectives / Segmentation Covered

By Type
  • Roll-On Antiperspirants
  • Spray Antiperspirants
  • Stick Antiperspirants
By Application
  • Men
  • Women
By End-users
  • Men
  • Women

By Distribution Channel
  • Supermarket/Hypermarket
  • Convenience Stores
  • Specialty Stores
  • Online Stores

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Excessive Sweating among People
      • 3.2.2. High Benefits of the Antiperspirant
      • 3.2.3. Increased Number of Promotional Activities by Manufacturers
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness about Antiperspirant in Some regions
    • 3.4. Market Trends
      • 3.4.1. Robust Increase in the Distribution Channels
      • 3.4.2. Increased Number of Online Customers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antiperspirant, by Type, Application, End-users, Distribution Channel and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antiperspirant (Value)
      • 5.2.1. Global Antiperspirant by: Type (Value)
        • 5.2.1.1. Roll-On Antiperspirants
        • 5.2.1.2. Spray Antiperspirants
        • 5.2.1.3. Stick Antiperspirants
      • 5.2.2. Global Antiperspirant by: Application (Value)
        • 5.2.2.1. Men
        • 5.2.2.2. Women
      • 5.2.3. Global Antiperspirant by: End-users (Value)
        • 5.2.3.1. Men
        • 5.2.3.2. Women
      • 5.2.4. Global Antiperspirant by: Distribution Channel (Value)
        • 5.2.4.1. Supermarket/Hypermarket
        • 5.2.4.2. Convenience Stores
        • 5.2.4.3. Specialty Stores
        • 5.2.4.4. Online Stores
      • 5.2.5. Global Antiperspirant Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Antiperspirant (Volume)
      • 5.3.1. Global Antiperspirant by: Type (Volume)
        • 5.3.1.1. Roll-On Antiperspirants
        • 5.3.1.2. Spray Antiperspirants
        • 5.3.1.3. Stick Antiperspirants
      • 5.3.2. Global Antiperspirant by: Application (Volume)
        • 5.3.2.1. Men
        • 5.3.2.2. Women
      • 5.3.3. Global Antiperspirant by: End-users (Volume)
        • 5.3.3.1. Men
        • 5.3.3.2. Women
      • 5.3.4. Global Antiperspirant by: Distribution Channel (Volume)
        • 5.3.4.1. Supermarket/Hypermarket
        • 5.3.4.2. Convenience Stores
        • 5.3.4.3. Specialty Stores
        • 5.3.4.4. Online Stores
      • 5.3.5. Global Antiperspirant Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Antiperspirant (Price)
      • 5.4.1. Global Antiperspirant by: Type (Price)
  • 6. Antiperspirant: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Unilever plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Amway (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beiersdorf AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mentholatum (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Coty Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Avon Products, Inc. (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shanghai Jahwa United Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Gialen Cosmetics (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sephora (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Antiperspirant Sale, by Type, Application, End-users, Distribution Channel and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antiperspirant (Value)
      • 7.2.1. Global Antiperspirant by: Type (Value)
        • 7.2.1.1. Roll-On Antiperspirants
        • 7.2.1.2. Spray Antiperspirants
        • 7.2.1.3. Stick Antiperspirants
      • 7.2.2. Global Antiperspirant by: Application (Value)
        • 7.2.2.1. Men
        • 7.2.2.2. Women
      • 7.2.3. Global Antiperspirant by: End-users (Value)
        • 7.2.3.1. Men
        • 7.2.3.2. Women
      • 7.2.4. Global Antiperspirant by: Distribution Channel (Value)
        • 7.2.4.1. Supermarket/Hypermarket
        • 7.2.4.2. Convenience Stores
        • 7.2.4.3. Specialty Stores
        • 7.2.4.4. Online Stores
      • 7.2.5. Global Antiperspirant Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Antiperspirant (Volume)
      • 7.3.1. Global Antiperspirant by: Type (Volume)
        • 7.3.1.1. Roll-On Antiperspirants
        • 7.3.1.2. Spray Antiperspirants
        • 7.3.1.3. Stick Antiperspirants
      • 7.3.2. Global Antiperspirant by: Application (Volume)
        • 7.3.2.1. Men
        • 7.3.2.2. Women
      • 7.3.3. Global Antiperspirant by: End-users (Volume)
        • 7.3.3.1. Men
        • 7.3.3.2. Women
      • 7.3.4. Global Antiperspirant by: Distribution Channel (Volume)
        • 7.3.4.1. Supermarket/Hypermarket
        • 7.3.4.2. Convenience Stores
        • 7.3.4.3. Specialty Stores
        • 7.3.4.4. Online Stores
      • 7.3.5. Global Antiperspirant Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Antiperspirant (Price)
      • 7.4.1. Global Antiperspirant by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antiperspirant: by Type(USD Million)
  • Table 2. Antiperspirant Roll-On Antiperspirants , by Region USD Million (2017-2022)
  • Table 3. Antiperspirant Spray Antiperspirants , by Region USD Million (2017-2022)
  • Table 4. Antiperspirant Stick Antiperspirants , by Region USD Million (2017-2022)
  • Table 5. Antiperspirant: by Application(USD Million)
  • Table 6. Antiperspirant Men , by Region USD Million (2017-2022)
  • Table 7. Antiperspirant Women , by Region USD Million (2017-2022)
  • Table 8. Antiperspirant: by End-users(USD Million)
  • Table 9. Antiperspirant Men , by Region USD Million (2017-2022)
  • Table 10. Antiperspirant Women , by Region USD Million (2017-2022)
  • Table 11. Antiperspirant: by Distribution Channel(USD Million)
  • Table 12. Antiperspirant Supermarket/Hypermarket , by Region USD Million (2017-2022)
  • Table 13. Antiperspirant Convenience Stores , by Region USD Million (2017-2022)
  • Table 14. Antiperspirant Specialty Stores , by Region USD Million (2017-2022)
  • Table 15. Antiperspirant Online Stores , by Region USD Million (2017-2022)
  • Table 16. South America Antiperspirant, by Country USD Million (2017-2022)
  • Table 17. South America Antiperspirant, by Type USD Million (2017-2022)
  • Table 18. South America Antiperspirant, by Application USD Million (2017-2022)
  • Table 19. South America Antiperspirant, by End-users USD Million (2017-2022)
  • Table 20. South America Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 21. Brazil Antiperspirant, by Type USD Million (2017-2022)
  • Table 22. Brazil Antiperspirant, by Application USD Million (2017-2022)
  • Table 23. Brazil Antiperspirant, by End-users USD Million (2017-2022)
  • Table 24. Brazil Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 25. Argentina Antiperspirant, by Type USD Million (2017-2022)
  • Table 26. Argentina Antiperspirant, by Application USD Million (2017-2022)
  • Table 27. Argentina Antiperspirant, by End-users USD Million (2017-2022)
  • Table 28. Argentina Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 29. Rest of South America Antiperspirant, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Antiperspirant, by Application USD Million (2017-2022)
  • Table 31. Rest of South America Antiperspirant, by End-users USD Million (2017-2022)
  • Table 32. Rest of South America Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 33. Asia Pacific Antiperspirant, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Antiperspirant, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Antiperspirant, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Antiperspirant, by End-users USD Million (2017-2022)
  • Table 37. Asia Pacific Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 38. China Antiperspirant, by Type USD Million (2017-2022)
  • Table 39. China Antiperspirant, by Application USD Million (2017-2022)
  • Table 40. China Antiperspirant, by End-users USD Million (2017-2022)
  • Table 41. China Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 42. Japan Antiperspirant, by Type USD Million (2017-2022)
  • Table 43. Japan Antiperspirant, by Application USD Million (2017-2022)
  • Table 44. Japan Antiperspirant, by End-users USD Million (2017-2022)
  • Table 45. Japan Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 46. India Antiperspirant, by Type USD Million (2017-2022)
  • Table 47. India Antiperspirant, by Application USD Million (2017-2022)
  • Table 48. India Antiperspirant, by End-users USD Million (2017-2022)
  • Table 49. India Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 50. South Korea Antiperspirant, by Type USD Million (2017-2022)
  • Table 51. South Korea Antiperspirant, by Application USD Million (2017-2022)
  • Table 52. South Korea Antiperspirant, by End-users USD Million (2017-2022)
  • Table 53. South Korea Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 54. Taiwan Antiperspirant, by Type USD Million (2017-2022)
  • Table 55. Taiwan Antiperspirant, by Application USD Million (2017-2022)
  • Table 56. Taiwan Antiperspirant, by End-users USD Million (2017-2022)
  • Table 57. Taiwan Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 58. Australia Antiperspirant, by Type USD Million (2017-2022)
  • Table 59. Australia Antiperspirant, by Application USD Million (2017-2022)
  • Table 60. Australia Antiperspirant, by End-users USD Million (2017-2022)
  • Table 61. Australia Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Antiperspirant, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Antiperspirant, by Application USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Antiperspirant, by End-users USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 66. Europe Antiperspirant, by Country USD Million (2017-2022)
  • Table 67. Europe Antiperspirant, by Type USD Million (2017-2022)
  • Table 68. Europe Antiperspirant, by Application USD Million (2017-2022)
  • Table 69. Europe Antiperspirant, by End-users USD Million (2017-2022)
  • Table 70. Europe Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 71. Germany Antiperspirant, by Type USD Million (2017-2022)
  • Table 72. Germany Antiperspirant, by Application USD Million (2017-2022)
  • Table 73. Germany Antiperspirant, by End-users USD Million (2017-2022)
  • Table 74. Germany Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 75. France Antiperspirant, by Type USD Million (2017-2022)
  • Table 76. France Antiperspirant, by Application USD Million (2017-2022)
  • Table 77. France Antiperspirant, by End-users USD Million (2017-2022)
  • Table 78. France Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 79. Italy Antiperspirant, by Type USD Million (2017-2022)
  • Table 80. Italy Antiperspirant, by Application USD Million (2017-2022)
  • Table 81. Italy Antiperspirant, by End-users USD Million (2017-2022)
  • Table 82. Italy Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 83. United Kingdom Antiperspirant, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Antiperspirant, by Application USD Million (2017-2022)
  • Table 85. United Kingdom Antiperspirant, by End-users USD Million (2017-2022)
  • Table 86. United Kingdom Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 87. Netherlands Antiperspirant, by Type USD Million (2017-2022)
  • Table 88. Netherlands Antiperspirant, by Application USD Million (2017-2022)
  • Table 89. Netherlands Antiperspirant, by End-users USD Million (2017-2022)
  • Table 90. Netherlands Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 91. Rest of Europe Antiperspirant, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Antiperspirant, by Application USD Million (2017-2022)
  • Table 93. Rest of Europe Antiperspirant, by End-users USD Million (2017-2022)
  • Table 94. Rest of Europe Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 95. MEA Antiperspirant, by Country USD Million (2017-2022)
  • Table 96. MEA Antiperspirant, by Type USD Million (2017-2022)
  • Table 97. MEA Antiperspirant, by Application USD Million (2017-2022)
  • Table 98. MEA Antiperspirant, by End-users USD Million (2017-2022)
  • Table 99. MEA Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 100. Middle East Antiperspirant, by Type USD Million (2017-2022)
  • Table 101. Middle East Antiperspirant, by Application USD Million (2017-2022)
  • Table 102. Middle East Antiperspirant, by End-users USD Million (2017-2022)
  • Table 103. Middle East Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 104. Africa Antiperspirant, by Type USD Million (2017-2022)
  • Table 105. Africa Antiperspirant, by Application USD Million (2017-2022)
  • Table 106. Africa Antiperspirant, by End-users USD Million (2017-2022)
  • Table 107. Africa Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 108. North America Antiperspirant, by Country USD Million (2017-2022)
  • Table 109. North America Antiperspirant, by Type USD Million (2017-2022)
  • Table 110. North America Antiperspirant, by Application USD Million (2017-2022)
  • Table 111. North America Antiperspirant, by End-users USD Million (2017-2022)
  • Table 112. North America Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 113. United States Antiperspirant, by Type USD Million (2017-2022)
  • Table 114. United States Antiperspirant, by Application USD Million (2017-2022)
  • Table 115. United States Antiperspirant, by End-users USD Million (2017-2022)
  • Table 116. United States Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 117. Canada Antiperspirant, by Type USD Million (2017-2022)
  • Table 118. Canada Antiperspirant, by Application USD Million (2017-2022)
  • Table 119. Canada Antiperspirant, by End-users USD Million (2017-2022)
  • Table 120. Canada Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 121. Mexico Antiperspirant, by Type USD Million (2017-2022)
  • Table 122. Mexico Antiperspirant, by Application USD Million (2017-2022)
  • Table 123. Mexico Antiperspirant, by End-users USD Million (2017-2022)
  • Table 124. Mexico Antiperspirant, by Distribution Channel USD Million (2017-2022)
  • Table 125. Antiperspirant Sales: by Type(K Units)
  • Table 126. Antiperspirant Sales Roll-On Antiperspirants , by Region K Units (2017-2022)
  • Table 127. Antiperspirant Sales Spray Antiperspirants , by Region K Units (2017-2022)
  • Table 128. Antiperspirant Sales Stick Antiperspirants , by Region K Units (2017-2022)
  • Table 129. Antiperspirant Sales: by Application(K Units)
  • Table 130. Antiperspirant Sales Men , by Region K Units (2017-2022)
  • Table 131. Antiperspirant Sales Women , by Region K Units (2017-2022)
  • Table 132. Antiperspirant Sales: by End-users(K Units)
  • Table 133. Antiperspirant Sales Men , by Region K Units (2017-2022)
  • Table 134. Antiperspirant Sales Women , by Region K Units (2017-2022)
  • Table 135. Antiperspirant Sales: by Distribution Channel(K Units)
  • Table 136. Antiperspirant Sales Supermarket/Hypermarket , by Region K Units (2017-2022)
  • Table 137. Antiperspirant Sales Convenience Stores , by Region K Units (2017-2022)
  • Table 138. Antiperspirant Sales Specialty Stores , by Region K Units (2017-2022)
  • Table 139. Antiperspirant Sales Online Stores , by Region K Units (2017-2022)
  • Table 140. South America Antiperspirant Sales, by Country K Units (2017-2022)
  • Table 141. South America Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 142. South America Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 143. South America Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 144. South America Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 145. Brazil Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 146. Brazil Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 147. Brazil Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 148. Brazil Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 149. Argentina Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 150. Argentina Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 151. Argentina Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 152. Argentina Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 153. Rest of South America Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 154. Rest of South America Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 155. Rest of South America Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 156. Rest of South America Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 157. Asia Pacific Antiperspirant Sales, by Country K Units (2017-2022)
  • Table 158. Asia Pacific Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 159. Asia Pacific Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 160. Asia Pacific Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 161. Asia Pacific Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 162. China Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 163. China Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 164. China Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 165. China Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 166. Japan Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 167. Japan Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 168. Japan Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 169. Japan Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 170. India Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 171. India Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 172. India Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 173. India Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 174. South Korea Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 175. South Korea Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 176. South Korea Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 177. South Korea Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 178. Taiwan Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 179. Taiwan Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 180. Taiwan Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 181. Taiwan Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 182. Australia Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 183. Australia Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 184. Australia Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 185. Australia Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 186. Rest of Asia-Pacific Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 187. Rest of Asia-Pacific Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 188. Rest of Asia-Pacific Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 189. Rest of Asia-Pacific Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 190. Europe Antiperspirant Sales, by Country K Units (2017-2022)
  • Table 191. Europe Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 192. Europe Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 193. Europe Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 194. Europe Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 195. Germany Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 196. Germany Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 197. Germany Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 198. Germany Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 199. France Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 200. France Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 201. France Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 202. France Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 203. Italy Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 204. Italy Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 205. Italy Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 206. Italy Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 207. United Kingdom Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 208. United Kingdom Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 209. United Kingdom Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 210. United Kingdom Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 211. Netherlands Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 212. Netherlands Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 213. Netherlands Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 214. Netherlands Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 215. Rest of Europe Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 216. Rest of Europe Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 217. Rest of Europe Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 218. Rest of Europe Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 219. MEA Antiperspirant Sales, by Country K Units (2017-2022)
  • Table 220. MEA Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 221. MEA Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 222. MEA Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 223. MEA Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 224. Middle East Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 225. Middle East Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 226. Middle East Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 227. Middle East Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 228. Africa Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 229. Africa Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 230. Africa Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 231. Africa Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 232. North America Antiperspirant Sales, by Country K Units (2017-2022)
  • Table 233. North America Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 234. North America Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 235. North America Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 236. North America Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 237. United States Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 238. United States Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 239. United States Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 240. United States Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 241. Canada Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 242. Canada Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 243. Canada Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 244. Canada Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 245. Mexico Antiperspirant Sales, by Type K Units (2017-2022)
  • Table 246. Mexico Antiperspirant Sales, by Application K Units (2017-2022)
  • Table 247. Mexico Antiperspirant Sales, by End-users K Units (2017-2022)
  • Table 248. Mexico Antiperspirant Sales, by Distribution Channel K Units (2017-2022)
  • Table 249. Antiperspirant: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Antiperspirant: by Type(USD Million)
  • Table 260. Antiperspirant Roll-On Antiperspirants , by Region USD Million (2023-2028)
  • Table 261. Antiperspirant Spray Antiperspirants , by Region USD Million (2023-2028)
  • Table 262. Antiperspirant Stick Antiperspirants , by Region USD Million (2023-2028)
  • Table 263. Antiperspirant: by Application(USD Million)
  • Table 264. Antiperspirant Men , by Region USD Million (2023-2028)
  • Table 265. Antiperspirant Women , by Region USD Million (2023-2028)
  • Table 266. Antiperspirant: by End-users(USD Million)
  • Table 267. Antiperspirant Men , by Region USD Million (2023-2028)
  • Table 268. Antiperspirant Women , by Region USD Million (2023-2028)
  • Table 269. Antiperspirant: by Distribution Channel(USD Million)
  • Table 270. Antiperspirant Supermarket/Hypermarket , by Region USD Million (2023-2028)
  • Table 271. Antiperspirant Convenience Stores , by Region USD Million (2023-2028)
  • Table 272. Antiperspirant Specialty Stores , by Region USD Million (2023-2028)
  • Table 273. Antiperspirant Online Stores , by Region USD Million (2023-2028)
  • Table 274. South America Antiperspirant, by Country USD Million (2023-2028)
  • Table 275. South America Antiperspirant, by Type USD Million (2023-2028)
  • Table 276. South America Antiperspirant, by Application USD Million (2023-2028)
  • Table 277. South America Antiperspirant, by End-users USD Million (2023-2028)
  • Table 278. South America Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 279. Brazil Antiperspirant, by Type USD Million (2023-2028)
  • Table 280. Brazil Antiperspirant, by Application USD Million (2023-2028)
  • Table 281. Brazil Antiperspirant, by End-users USD Million (2023-2028)
  • Table 282. Brazil Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 283. Argentina Antiperspirant, by Type USD Million (2023-2028)
  • Table 284. Argentina Antiperspirant, by Application USD Million (2023-2028)
  • Table 285. Argentina Antiperspirant, by End-users USD Million (2023-2028)
  • Table 286. Argentina Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 287. Rest of South America Antiperspirant, by Type USD Million (2023-2028)
  • Table 288. Rest of South America Antiperspirant, by Application USD Million (2023-2028)
  • Table 289. Rest of South America Antiperspirant, by End-users USD Million (2023-2028)
  • Table 290. Rest of South America Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 291. Asia Pacific Antiperspirant, by Country USD Million (2023-2028)
  • Table 292. Asia Pacific Antiperspirant, by Type USD Million (2023-2028)
  • Table 293. Asia Pacific Antiperspirant, by Application USD Million (2023-2028)
  • Table 294. Asia Pacific Antiperspirant, by End-users USD Million (2023-2028)
  • Table 295. Asia Pacific Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 296. China Antiperspirant, by Type USD Million (2023-2028)
  • Table 297. China Antiperspirant, by Application USD Million (2023-2028)
  • Table 298. China Antiperspirant, by End-users USD Million (2023-2028)
  • Table 299. China Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 300. Japan Antiperspirant, by Type USD Million (2023-2028)
  • Table 301. Japan Antiperspirant, by Application USD Million (2023-2028)
  • Table 302. Japan Antiperspirant, by End-users USD Million (2023-2028)
  • Table 303. Japan Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 304. India Antiperspirant, by Type USD Million (2023-2028)
  • Table 305. India Antiperspirant, by Application USD Million (2023-2028)
  • Table 306. India Antiperspirant, by End-users USD Million (2023-2028)
  • Table 307. India Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 308. South Korea Antiperspirant, by Type USD Million (2023-2028)
  • Table 309. South Korea Antiperspirant, by Application USD Million (2023-2028)
  • Table 310. South Korea Antiperspirant, by End-users USD Million (2023-2028)
  • Table 311. South Korea Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 312. Taiwan Antiperspirant, by Type USD Million (2023-2028)
  • Table 313. Taiwan Antiperspirant, by Application USD Million (2023-2028)
  • Table 314. Taiwan Antiperspirant, by End-users USD Million (2023-2028)
  • Table 315. Taiwan Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 316. Australia Antiperspirant, by Type USD Million (2023-2028)
  • Table 317. Australia Antiperspirant, by Application USD Million (2023-2028)
  • Table 318. Australia Antiperspirant, by End-users USD Million (2023-2028)
  • Table 319. Australia Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 320. Rest of Asia-Pacific Antiperspirant, by Type USD Million (2023-2028)
  • Table 321. Rest of Asia-Pacific Antiperspirant, by Application USD Million (2023-2028)
  • Table 322. Rest of Asia-Pacific Antiperspirant, by End-users USD Million (2023-2028)
  • Table 323. Rest of Asia-Pacific Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 324. Europe Antiperspirant, by Country USD Million (2023-2028)
  • Table 325. Europe Antiperspirant, by Type USD Million (2023-2028)
  • Table 326. Europe Antiperspirant, by Application USD Million (2023-2028)
  • Table 327. Europe Antiperspirant, by End-users USD Million (2023-2028)
  • Table 328. Europe Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 329. Germany Antiperspirant, by Type USD Million (2023-2028)
  • Table 330. Germany Antiperspirant, by Application USD Million (2023-2028)
  • Table 331. Germany Antiperspirant, by End-users USD Million (2023-2028)
  • Table 332. Germany Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 333. France Antiperspirant, by Type USD Million (2023-2028)
  • Table 334. France Antiperspirant, by Application USD Million (2023-2028)
  • Table 335. France Antiperspirant, by End-users USD Million (2023-2028)
  • Table 336. France Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 337. Italy Antiperspirant, by Type USD Million (2023-2028)
  • Table 338. Italy Antiperspirant, by Application USD Million (2023-2028)
  • Table 339. Italy Antiperspirant, by End-users USD Million (2023-2028)
  • Table 340. Italy Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 341. United Kingdom Antiperspirant, by Type USD Million (2023-2028)
  • Table 342. United Kingdom Antiperspirant, by Application USD Million (2023-2028)
  • Table 343. United Kingdom Antiperspirant, by End-users USD Million (2023-2028)
  • Table 344. United Kingdom Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 345. Netherlands Antiperspirant, by Type USD Million (2023-2028)
  • Table 346. Netherlands Antiperspirant, by Application USD Million (2023-2028)
  • Table 347. Netherlands Antiperspirant, by End-users USD Million (2023-2028)
  • Table 348. Netherlands Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 349. Rest of Europe Antiperspirant, by Type USD Million (2023-2028)
  • Table 350. Rest of Europe Antiperspirant, by Application USD Million (2023-2028)
  • Table 351. Rest of Europe Antiperspirant, by End-users USD Million (2023-2028)
  • Table 352. Rest of Europe Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 353. MEA Antiperspirant, by Country USD Million (2023-2028)
  • Table 354. MEA Antiperspirant, by Type USD Million (2023-2028)
  • Table 355. MEA Antiperspirant, by Application USD Million (2023-2028)
  • Table 356. MEA Antiperspirant, by End-users USD Million (2023-2028)
  • Table 357. MEA Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 358. Middle East Antiperspirant, by Type USD Million (2023-2028)
  • Table 359. Middle East Antiperspirant, by Application USD Million (2023-2028)
  • Table 360. Middle East Antiperspirant, by End-users USD Million (2023-2028)
  • Table 361. Middle East Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 362. Africa Antiperspirant, by Type USD Million (2023-2028)
  • Table 363. Africa Antiperspirant, by Application USD Million (2023-2028)
  • Table 364. Africa Antiperspirant, by End-users USD Million (2023-2028)
  • Table 365. Africa Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 366. North America Antiperspirant, by Country USD Million (2023-2028)
  • Table 367. North America Antiperspirant, by Type USD Million (2023-2028)
  • Table 368. North America Antiperspirant, by Application USD Million (2023-2028)
  • Table 369. North America Antiperspirant, by End-users USD Million (2023-2028)
  • Table 370. North America Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 371. United States Antiperspirant, by Type USD Million (2023-2028)
  • Table 372. United States Antiperspirant, by Application USD Million (2023-2028)
  • Table 373. United States Antiperspirant, by End-users USD Million (2023-2028)
  • Table 374. United States Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 375. Canada Antiperspirant, by Type USD Million (2023-2028)
  • Table 376. Canada Antiperspirant, by Application USD Million (2023-2028)
  • Table 377. Canada Antiperspirant, by End-users USD Million (2023-2028)
  • Table 378. Canada Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 379. Mexico Antiperspirant, by Type USD Million (2023-2028)
  • Table 380. Mexico Antiperspirant, by Application USD Million (2023-2028)
  • Table 381. Mexico Antiperspirant, by End-users USD Million (2023-2028)
  • Table 382. Mexico Antiperspirant, by Distribution Channel USD Million (2023-2028)
  • Table 383. Antiperspirant Sales: by Type(K Units)
  • Table 384. Antiperspirant Sales Roll-On Antiperspirants , by Region K Units (2023-2028)
  • Table 385. Antiperspirant Sales Spray Antiperspirants , by Region K Units (2023-2028)
  • Table 386. Antiperspirant Sales Stick Antiperspirants , by Region K Units (2023-2028)
  • Table 387. Antiperspirant Sales: by Application(K Units)
  • Table 388. Antiperspirant Sales Men , by Region K Units (2023-2028)
  • Table 389. Antiperspirant Sales Women , by Region K Units (2023-2028)
  • Table 390. Antiperspirant Sales: by End-users(K Units)
  • Table 391. Antiperspirant Sales Men , by Region K Units (2023-2028)
  • Table 392. Antiperspirant Sales Women , by Region K Units (2023-2028)
  • Table 393. Antiperspirant Sales: by Distribution Channel(K Units)
  • Table 394. Antiperspirant Sales Supermarket/Hypermarket , by Region K Units (2023-2028)
  • Table 395. Antiperspirant Sales Convenience Stores , by Region K Units (2023-2028)
  • Table 396. Antiperspirant Sales Specialty Stores , by Region K Units (2023-2028)
  • Table 397. Antiperspirant Sales Online Stores , by Region K Units (2023-2028)
  • Table 398. South America Antiperspirant Sales, by Country K Units (2023-2028)
  • Table 399. South America Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 400. South America Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 401. South America Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 402. South America Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 403. Brazil Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 404. Brazil Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 405. Brazil Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 406. Brazil Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 407. Argentina Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 408. Argentina Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 409. Argentina Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 410. Argentina Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 411. Rest of South America Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 412. Rest of South America Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 413. Rest of South America Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 414. Rest of South America Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 415. Asia Pacific Antiperspirant Sales, by Country K Units (2023-2028)
  • Table 416. Asia Pacific Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 417. Asia Pacific Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 418. Asia Pacific Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 419. Asia Pacific Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 420. China Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 421. China Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 422. China Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 423. China Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 424. Japan Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 425. Japan Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 426. Japan Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 427. Japan Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 428. India Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 429. India Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 430. India Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 431. India Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 432. South Korea Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 433. South Korea Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 434. South Korea Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 435. South Korea Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 436. Taiwan Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 437. Taiwan Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 438. Taiwan Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 439. Taiwan Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 440. Australia Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 441. Australia Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 442. Australia Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 443. Australia Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 444. Rest of Asia-Pacific Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 445. Rest of Asia-Pacific Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 446. Rest of Asia-Pacific Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 447. Rest of Asia-Pacific Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 448. Europe Antiperspirant Sales, by Country K Units (2023-2028)
  • Table 449. Europe Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 450. Europe Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 451. Europe Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 452. Europe Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 453. Germany Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 454. Germany Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 455. Germany Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 456. Germany Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 457. France Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 458. France Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 459. France Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 460. France Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 461. Italy Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 462. Italy Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 463. Italy Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 464. Italy Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 465. United Kingdom Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 466. United Kingdom Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 467. United Kingdom Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 468. United Kingdom Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 469. Netherlands Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 470. Netherlands Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 471. Netherlands Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 472. Netherlands Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 473. Rest of Europe Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 474. Rest of Europe Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 475. Rest of Europe Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 476. Rest of Europe Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 477. MEA Antiperspirant Sales, by Country K Units (2023-2028)
  • Table 478. MEA Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 479. MEA Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 480. MEA Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 481. MEA Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 482. Middle East Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 483. Middle East Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 484. Middle East Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 485. Middle East Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 486. Africa Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 487. Africa Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 488. Africa Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 489. Africa Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 490. North America Antiperspirant Sales, by Country K Units (2023-2028)
  • Table 491. North America Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 492. North America Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 493. North America Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 494. North America Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 495. United States Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 496. United States Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 497. United States Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 498. United States Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 499. Canada Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 500. Canada Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 501. Canada Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 502. Canada Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 503. Mexico Antiperspirant Sales, by Type K Units (2023-2028)
  • Table 504. Mexico Antiperspirant Sales, by Application K Units (2023-2028)
  • Table 505. Mexico Antiperspirant Sales, by End-users K Units (2023-2028)
  • Table 506. Mexico Antiperspirant Sales, by Distribution Channel K Units (2023-2028)
  • Table 507. Antiperspirant: by Type(USD/Units)
  • Table 508. Research Programs/Design for This Report
  • Table 509. Key Data Information from Secondary Sources
  • Table 510. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antiperspirant: by Type USD Million (2017-2022)
  • Figure 5. Global Antiperspirant: by Application USD Million (2017-2022)
  • Figure 6. Global Antiperspirant: by End-users USD Million (2017-2022)
  • Figure 7. Global Antiperspirant: by Distribution Channel USD Million (2017-2022)
  • Figure 8. South America Antiperspirant Share (%), by Country
  • Figure 9. Asia Pacific Antiperspirant Share (%), by Country
  • Figure 10. Europe Antiperspirant Share (%), by Country
  • Figure 11. MEA Antiperspirant Share (%), by Country
  • Figure 12. North America Antiperspirant Share (%), by Country
  • Figure 13. Global Antiperspirant: by Type K Units (2017-2022)
  • Figure 14. Global Antiperspirant: by Application K Units (2017-2022)
  • Figure 15. Global Antiperspirant: by End-users K Units (2017-2022)
  • Figure 16. Global Antiperspirant: by Distribution Channel K Units (2017-2022)
  • Figure 17. South America Antiperspirant Share (%), by Country
  • Figure 18. Asia Pacific Antiperspirant Share (%), by Country
  • Figure 19. Europe Antiperspirant Share (%), by Country
  • Figure 20. MEA Antiperspirant Share (%), by Country
  • Figure 21. North America Antiperspirant Share (%), by Country
  • Figure 22. Global Antiperspirant: by Type USD/Units (2017-2022)
  • Figure 23. Global Antiperspirant share by Players 2022 (%)
  • Figure 24. Global Antiperspirant share by Players (Top 3) 2022(%)
  • Figure 25. Global Antiperspirant share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Unilever plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Unilever plc (United Kingdom) Revenue: by Geography 2022
  • Figure 29. Amway (United States) Revenue, Net Income and Gross profit
  • Figure 30. Amway (United States) Revenue: by Geography 2022
  • Figure 31. Beiersdorf AG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Beiersdorf AG (Germany) Revenue: by Geography 2022
  • Figure 33. Mentholatum (United States) Revenue, Net Income and Gross profit
  • Figure 34. Mentholatum (United States) Revenue: by Geography 2022
  • Figure 35. Coty Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Coty Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Avon Products, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Avon Products, Inc. (United Kingdom) Revenue: by Geography 2022
  • Figure 39. Shanghai Jahwa United Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 40. Shanghai Jahwa United Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 41. Gialen Cosmetics (China) Revenue, Net Income and Gross profit
  • Figure 42. Gialen Cosmetics (China) Revenue: by Geography 2022
  • Figure 43. Sephora (France) Revenue, Net Income and Gross profit
  • Figure 44. Sephora (France) Revenue: by Geography 2022
  • Figure 45. Global Antiperspirant: by Type USD Million (2023-2028)
  • Figure 46. Global Antiperspirant: by Application USD Million (2023-2028)
  • Figure 47. Global Antiperspirant: by End-users USD Million (2023-2028)
  • Figure 48. Global Antiperspirant: by Distribution Channel USD Million (2023-2028)
  • Figure 49. South America Antiperspirant Share (%), by Country
  • Figure 50. Asia Pacific Antiperspirant Share (%), by Country
  • Figure 51. Europe Antiperspirant Share (%), by Country
  • Figure 52. MEA Antiperspirant Share (%), by Country
  • Figure 53. North America Antiperspirant Share (%), by Country
  • Figure 54. Global Antiperspirant: by Type K Units (2023-2028)
  • Figure 55. Global Antiperspirant: by Application K Units (2023-2028)
  • Figure 56. Global Antiperspirant: by End-users K Units (2023-2028)
  • Figure 57. Global Antiperspirant: by Distribution Channel K Units (2023-2028)
  • Figure 58. South America Antiperspirant Share (%), by Country
  • Figure 59. Asia Pacific Antiperspirant Share (%), by Country
  • Figure 60. Europe Antiperspirant Share (%), by Country
  • Figure 61. MEA Antiperspirant Share (%), by Country
  • Figure 62. North America Antiperspirant Share (%), by Country
  • Figure 63. Global Antiperspirant: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Unilever plc (United Kingdom)
  • Amway (United States)
  • Beiersdorf AG (Germany)
  • Mentholatum (United States)
  • Coty Inc. (United States)
  • Avon Products, Inc. (United Kingdom)
  • Shanghai Jahwa United Co., Ltd. (China)
  • Gialen Cosmetics (China)
  • Sephora (France)
Select User Access Type

Key Highlights of Report


May 2023 217 Pages 76 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antiperspirant Quantitative research analysis
Global Antiperspirant Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Excessive Sweating among People " is seen as one of major growth factors of Antiperspirant Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Antiperspirant market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Antiperspirant Report?

Have a Query? Click Here

Other Related Reports

Liquid Laundry Detergent Comprehensive Study by Type (Organic, Conventional), Application (Residential, Commercial (Textile Industry, Laundry services, and Hospitality Industry)), Packing Type (250 m...
$ 3750
Extra Virgin Olive Oil Comprehensive Study by Type (Virgin Olive Oil (Extra Virgin Olive Oil, Virgin Olive Oil and Lampante Olive Oil), Refined Olive Oil, Olive Oil, Crude Olive-Pomace Oil, Refined O...
$ 3750
White Noise Machine Comprehensive Study by Type (Plug-in, Portable, Stuffed Animal, Other), Application (Audio Testing, Sound Masking, Sleep-Aid, Power-Napping), Technology (Electronic (Digital), Mec...
$ 3650
Silicone Baking Mats Comprehensive Study by Type (Less than 5 Inches, 10-14 Inches, 14-20 Inches, 20-30 Inches, 30-40 Inches, Others), Application (Residential, Commercial), Shape (Square, Rectangle)...
$ 3650
Computer Carrying Case Comprehensive Study by Type (Backpack computer laptop carrying cases, Shoulder/sling PC computer laptop carrying cases), Application (Long Journey, Daily Travelling, Others), D...
$ 3450
Cosmetic Tubes Comprehensive Study by Type (Reflexion Laminate Tube, Artist Bubble Tube), Application (Skin Care, Hair Care, Makeup, Others (Nail Care & Hygiene Products)), Applicator (Pumps, Nozzles...
$ 3650